4 Life Science Cos. Set Terms For IPOs Totaling $276M
Four life science companies set terms for initial public offerings totaling about $276 million at their midpoint prices on Monday, joining the recent spate of biotech and health care-related offerings that...To view the full article, register now.
Already a subscriber? Click here to view full article